|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Costs and Expenses: | |||||
| Cost of revenue | |||||
| Research and development | |||||
| Sales and marketing | |||||
| General and administrative | |||||
| Change in fair value of contingent consideration related to earnouts | |||||
| Total costs and expenses | |||||
| Income from Operations | |||||
| Other income (expense), net: | |||||
| Interest income | |||||
| Interest expense | |||||
| Other gains (losses), net | |||||
| Total other income (expense), net | |||||
| Income before income taxes | |||||
| Income tax provision (benefit) | |||||
| Net Income (Loss) | |||||
| Net Income (Loss) per Share Attributable to Common Stockholders | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted-average Shares Used in Computing Net Income (Loss) per Share Attributable to Common Stockholders | |||||
| Basic (in shares) | |||||
| Diluted (in shares) |
Loading...